HOXB13 and prostate cancer: Patients with symptomatic Benign Prostatic Hyperplasia (BPH) showed upregulated gene expression of biological pathways associated with T cell activation and suppression of a key transcription factor HOXB13, which is associated with transcription and epigenetic regulation of prostate cancer (PCa).